Phase 2 Study to Evaluate Brincidofovir for the Prevention of Adenovirus Disease

Clinical trial NCT01241344 · COMPLETED

Trial details

NCT number: NCT01241344
Sponsor: Jazz Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenovirus Disease

Start date: 2010-11-01
Primary completion: 2013-06-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.